Insider · CIK 0002035175
Michael Elliot Shankman
Files at LEXX (Lexaria Bioscience Corp.). First filing -, latest -.
In brief
Michael Elliot Shankman files SEC Form 4 as CFO at LEXX (Lexaria Bioscience Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael Elliot Shankman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | LEXX Lexaria Bioscience Corp. | AGrant or award Stock Optionsderivative | +50,000 | $0.00 | $0 | 100,000 | May 16, 2025 |
Questions about Michael Elliot Shankman
Answered from the filings on this page, as of the latest one.
Is Michael Elliot Shankman buying or selling?
Michael Elliot Shankman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael Elliot Shankman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Elliot Shankman has 0.
Where does Michael Elliot Shankman file Form 4?
Michael Elliot Shankman has filed Form 4 at LEXX (Lexaria Bioscience Corp.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.